Shweta Bansal, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Shweta Bansal is a Nephrology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 119 publications with 3,062 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
15102 Huebner Rd
San Antonio, TX 782311739
Telephone
210-644-2400Provider last certified this registry record 14 May 2026.
Clinical trials
- High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
Sponsor: The University of Texas Health Science Center at San Antonio
- Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202519 payments$24,087openpaymentsdata.cms.gov ↗
- Calliditas Therapeutics US Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
57.2%Loop diuretic18.6%Torsemide86%Furosemide14%Part D<11 patientsBeta blocker11.3%Carvedilol71%Metoprolol Succinate29%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
26.7%Potassium supplement10.5%Potassium Chloride77%Klor-Con M2023%Part D<11 patientsSGLT2 inhibitor6.7%Jardiance52%Farxiga49%Part D<11 patients+ 3 more classes in this area
Sensory organs
5.1%Aminoglycoside Antibacterial5.1%Gentamicin Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The chromatin landscape of healthy and injured cell types in the human kidney
Nature Communications
2024 - Rising Prevalence of Obesity and Primary Hyperaldosteronism: Co-incidence or Connected Circumstances Leading to Hypertension? A Narrative Review
Journal of General Internal Medicine
2024 - Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
Journal of Clinical Hypertension
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”